Page 86 - Sohini Das

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose

Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July

Colour-coded doses will have two different antigens

Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India

Second Covid-19 wave: Govt releases vaccines; not enough, says Maharashtra

One of the largest government-run vaccination sites in Mumbai on the Bandra Kurla Complex grounds has only 350 vaccine doses left

Remdesivir output to be ramped up as Covid-19 cases rise sharply

Zydus had recently also slashed prices of its remdesivir brand Remdac to Rs 899 per dose

Second Covid wave: Fatalities threaten to be worse this time, shows data

Deaths due to Covid-19 usually happen two to three weeks after the diagnosis of the disease, according to research and doctors' accounts

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

Panacea Biotec to make 100 mn doses of Sputnik V for global markets

More players like Serum Institute expected to join the fray to make Sputnik V

Weekend lockdown, night curfew in Maharashtra as Covid-19 cases surge

Stricter curbs from Monday; Mumbai civic authorities brace for 10,000 daily cases from next week as available beds in hospitals dry up. The city reported 9,108 cases on Sunday

Serum Institute may apply to sell Covid-19 vaccine Covishield commercially

No Covid vaccine in the world has marketing authorisation allowing sales in private market

Expert panel defers decision on Sputnik V Covid-19 vaccine, wants more data

Details of -25°C cold chain plan sought

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

Covid-19 vaccination: COVAX in talks with govt to ensure speedy deliveries

SII is committed to supplying 200 million doses to the collaboration